Anti-PRK3+PRK2+PRK1 (phospho T718 + T774 + T816) antibody [EPR1044(2)] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal PKN3 phospho T718 antibody. Carrier free. Suitable for IHC-P, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 1 publication.
View Alternative Names
PKNBETA, PKN3, Serine/threonine-protein kinase N3, Protein kinase PKN-beta, Protein-kinase C-related kinase 3, PAK1, PKN, PRK1, PRKCL1, PKN1, Serine/threonine-protein kinase N1, Protease-activated kinase 1, Protein kinase C-like 1, Protein kinase C-like PKN, Protein kinase PKN-alpha, Protein-kinase C-related kinase 1, Serine-threonine protein kinase N, PAK-1, PRK2, PRKCL2, PKN2, Serine/threonine-protein kinase N2, PKN gamma, Protein kinase C-like 2, Protein-kinase C-related kinase 2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRK3+PRK2+PRK1 (phospho T718 + T774 + T816) antibody [EPR1044(2)] - BSA and Azide free (AB250937)
This data was developed using ab187660, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human colon tissue labeling PRK3+PRK2+PRK1 (phospho T718 + T816 + T774) with ab187660 at 1/100 dilution, followed by prediluted HRP Polymer for Rabbit IgG. Counter stained with Hematoxylin.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRK3+PRK2+PRK1 (phospho T718 + T774 + T816) antibody [EPR1044(2)] - BSA and Azide free (AB250937)
This data was developed using ab187660, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human astrocytoma tissue labeling PRK3+PRK2+PRK1 (phospho T718 + T816 + T774) with ab187660 at 1/100 dilution, followed by prediluted HRP Polymer for Rabbit IgG. Counter stained with Hematoxylin.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-PRK3+PRK2+PRK1 (phospho T718 + T774 + T816) antibody [EPR1044(2)] - BSA and Azide free (AB250937)
This data was developed using ab187660, the same antibody clone in a different buffer formulation.
Intracellular flow cytometric analysis of permeabilized HeLa cells, untreated (green) or Okadaic acid + Calyculin A-treated (red) using ab187660 at 1/280 dilution, and Okadaic acid + Calyculin A-treated HeLa cells using ab187660 preincubated with phospho-PRK3+PRK2+PRK1 (phospho T718 + T816 + T774) peptide (blue) or non-phospho-PRK3+PRK2+PRK1 (phospho T718 + T816 + T774) peptide (orange). Cells were fixed with 2% paraformaldehyde. Secondary antibody was a Goat anti IgG (FITC) at 1/150 dilution.
- WB
Supplier Data
Western blot - Anti-PRK3+PRK2+PRK1 (phospho T718 + T774 + T816) antibody [EPR1044(2)] - BSA and Azide free (AB250937)
This data was developed using ab187660, the same antibody clone in a different buffer formulation.
Based on the sequence analysis, ab187660 recognizes three proteins with the predicted MWs of 99KDa, 112KDa and 104KDa, respectively.
All lanes:
Western blot - Anti-PRK3+PRK2+PRK1 (phospho T718 + T774 + T816) antibody [EPR1044(2)] (<a href='/en-us/products/primary-antibodies/prk3prk2prk1-phospho-t718-t774-t816-antibody-epr10442-ab187660'>ab187660</a>) at 1/10000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate treated with Okadaic acid + Calyculin A at 10 µg
Lane 2:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate, untreated at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 1 kDa,112 kDa,99 kDa
false
Related conjugates and formulations (1)
-
Anti-PRK3+PRK2+PRK1 (phospho T718 + T774 + T816) antibody [EPR1044(2)]
Reactivity data
Product details
ab250937 is the carrier-free version of ab187660.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PRK1 PRK2 and PRK3 act as downstream effectors of Rho GTPases which also suggests they can be involved in a complex. These kinases regulate actin cytoskeleton organization affecting cell shape and motility. PRK1 participates in processes like cell cycle progression and differentiation while PRK2 influences membrane trafficking and protein translation. PRK3 although less studied is similar in structure suggesting potential overlapping roles in cellular functions.
Pathways
PRK1 PRK2 and PRK3 integrate into the RhoA signaling pathway playing a part in actin remodeling. In particular PRK2 links closely to the mTOR pathway associated with cell growth and protein synthesis regulation. Through these pathways these kinases interact with other proteins such as Rho GTPases and mTORC1 coordinating a variety of critical cellular tasks and signaling events.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Endocrine-related cancer 25:35-50 PubMed29042395
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com